Suppr超能文献

宫颈和子宫内膜木质样变:先天性纤溶酶原缺乏的妇科表现。

Ligneous cervicitis and endometritis: A gynaecological presentation of congenital plasminogen deficiency.

机构信息

Department of Obstetrics and Gynaecology, The Royal Free Foundation NHS Trust, London, UK.

Department of Obstetrics and Gynaecology, The Whittington NHS Trust, London, UK.

出版信息

Haemophilia. 2018 May;24(3):359-365. doi: 10.1111/hae.13418. Epub 2018 Feb 13.

Abstract

BACKGROUND

Congenital plasminogen deficiency is a rare autosomal recessive condition. Plasminogen deficiency is thought to result in an inability of fibrin breakdown and therefore accumulation of fibrin and formation of ligneous changes. Ligneous lesions can form on a number of mucosal membranes including the cervix and endometrium.

METHODS

We report the case of a 25-year-old woman with type 1 plasminogen deficiency with ligneous cervicitis and endometritis and her treatment and clinical course over the last few years. We then review the current literature of ligneous cases of the female genital tract and discuss available treatment options.

KEY RESULTS

We found 30 reported cases of ligneous lesions affecting the female genital tract, with the cervix being the most affected part. A number of treatment options have been tried by our patient and other cases in the literature. These include use of the combined oral contraceptive pill, fresh frozen plasma infusion, topical plasmin and plasminogen and trial use of plasminogen concentrate.

CONCLUSIONS

This is a chronic condition requiring a multidisciplinary approach. There is currently no definitive treatment for the condition, current trials with plasminogen concentrate replacement therapy may provide a promising option for these patients in the future.

摘要

背景

先天性纤溶酶原缺乏症是一种罕见的常染色体隐性遗传病。纤溶酶原缺乏被认为导致纤维蛋白分解能力丧失,从而导致纤维蛋白积累和木质样改变的形成。木质样病变可发生在许多黏膜组织上,包括宫颈和子宫内膜。

方法

我们报告了一例 25 岁的 1 型纤溶酶原缺乏症患者,其患有木质样宫颈炎和子宫内膜炎,以及她在过去几年的治疗和临床过程。然后,我们回顾了目前关于女性生殖道木质样病变的文献,并讨论了可用的治疗选择。

结果

我们发现了 30 例报告的影响女性生殖道的木质样病变病例,其中宫颈是受影响最严重的部位。我们的患者和文献中的其他病例尝试了多种治疗选择。这些选择包括使用复方口服避孕药、新鲜冷冻血浆输注、局部纤溶酶和纤溶酶原以及尝试使用纤溶酶原浓缩物。

结论

这是一种需要多学科方法的慢性疾病。目前该病尚无明确的治疗方法,目前正在进行的纤溶酶原浓缩物替代治疗试验可能为未来这些患者提供一种有前途的选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验